Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro.
about
Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli.Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococciIn vitro pharmacodynamic studies of L-749,345 in comparison with imipenem and ceftriaxone against gram-positive and gram-negative bacteriaPharmacodynamics of telithromycin In vitro against respiratory tract pathogens.Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TBEffect of subinhibitory concentrations of fluoroquinolones on biofilm production by clinical isolates of Streptococcus pyogenesEffects of intracanal irrigant MTAD Combined with nisin at sub-minimum inhibitory concentration levels on Enterococcus faecalis growth and the expression of pathogenic genes.Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.Comparative study of bactericidal activities, postantibiotic effects, and effects of bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae.Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimensRationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies.Postantibiotic effect of sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and -resistant pneumococci.Delivering antibacterials to the lungs: considerations for optimizing outcomes.In vitro postantibiotic effect following repeated exposure to imipenem, temafloxacin, and tobramycinPharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.Postantibiotic, postantibiotic sub-MIC, and subinhibitory effects of PGE-9509924, ciprofloxacin, and levofloxacin.Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update.Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model.Pharmacological considerations for the proper clinical use of aminoglycosides.Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.Pharmacodynamic effects of subinhibitory concentrations of rufloxacin on bacterial virulence factors.In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidisPostantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens.Postantibiotic and post-beta-lactamase inhibitor effects of amoxicillin plus clavulanate.Pharmacodynamic effects of subinhibitory concentrations of imipenem on Pseudomonas aeruginosa in an in vitro dynamic model.Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacinA new method to determine postantibiotic effect and effects of subinhibitory antibiotic concentrationsAntibacterial activity of Harungana madagascariensis leaf extracts.Drug detoxification dynamics explain the postantibiotic effect.Efficacy and tolerability of once-daily cephalexin in canine superficial pyoderma: an open controlled study.Pharmacokinetics of two once-daily parenteral cephalexin formulations in dogs.Postantibiotic effects and postantibiotic sub-MIC effects of ciprofloxacin, pefloxacin and amikacin on the biological properties of Salmonella strains.Pharmacodynamic effects of meropenem on gram-negative bacteria.
P2860
Q33690065-A521E923-5738-4978-A017-6F4935AC5AC1Q33696032-010D5CC1-4A3D-4B42-B9CB-5D3F61DC3848Q33696946-B6B1C8B7-DD02-4ED6-AB11-74B3C0AC3BCCQ33981093-4DA4A5A9-53B1-4BA1-85D8-1132C6C4ED1DQ34307105-B84D2F86-B8D4-43E2-AD0D-F3F45FB517D4Q34591451-8CCF91DA-A559-4502-BEBE-83E4A69472DAQ34768908-34496394-175F-4128-8F3A-ABAF91121F43Q35113099-EFE355CD-00F2-4398-9283-E8C32F1A6EE4Q35128808-280D3F26-90B3-4EF6-A5D0-6CBDAAA7F116Q35134929-D27DAA12-357C-4FC0-BACB-DFF71350BEBAQ35135800-B76CDC45-BBB0-41F0-A741-9DF143132EB6Q35136933-B239961B-6E9A-4A51-A93C-D96568E77427Q35138044-074A61DF-FD70-45DF-AA15-88BA456ED21EQ35138485-22C97F12-5274-4E46-8EF4-CEB7BE934850Q35627814-13246DCF-51F2-4E04-91CF-F7C89E3BEECEQ35818258-EE3AB94B-FA60-40EF-AD8E-647CE8733A3BQ35819487-F56DBB5C-56CE-4791-93B6-128A95F2D094Q36048663-606176ED-62DB-4633-A4F8-7FEE0ED54613Q36072639-F66A0CD1-0D9A-425B-BBEE-EE4A30E1AAFAQ36758305-EC56817D-7575-418E-8777-E200CD6EEFF4Q37956403-77936D21-2E9B-4BCC-9C9B-9D25C3D10ED5Q38093135-E2DFFF06-9BED-4FCC-947E-790BD1C48E28Q39469972-9E8E3E5A-4D34-4A77-9479-75985C31D4DBQ39559251-6BA79166-7587-4F53-B669-CFA5C66A640DQ39778967-B244B5F8-B42A-4F9E-81B8-EA9FA666580BQ39783290-59688506-65C3-420D-9155-08FF076B56C8Q39867146-3F6FDA81-B8AC-4ED4-8A0C-986511F68567Q39881775-17B91E7F-AB21-442C-8471-04AA069FA64AQ39881971-B5C83878-EF74-4459-9B44-F8E64919635EQ43947575-2BA1A354-FF15-4FCE-9E89-BCA975AE4062Q44932110-301F8C48-7076-478D-A31E-D7393A87C027Q46480967-10CA3E2D-1EFE-4523-AEB3-0748E5ED08BBQ46737765-29A3A02F-342D-472E-B9DC-9B2FF6133A93Q46963879-1E76287E-5035-40E9-B085-5F8EC1DF0BD2Q54613484-1FD2235A-8CB4-40DE-A936-70478E2B446F
P2860
Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Pharmacodynamic effects of sub ...... a-lactam antibiotics in vitro.
@en
type
label
Pharmacodynamic effects of sub ...... a-lactam antibiotics in vitro.
@en
prefLabel
Pharmacodynamic effects of sub ...... a-lactam antibiotics in vitro.
@en
P2093
P2860
P356
P1476
Pharmacodynamic effects of sub ...... a-lactam antibiotics in vitro.
@en
P2093
Odenholt-Tornqvist I
P2860
P304
P356
10.1128/AAC.35.9.1834
P407
P577
1991-09-01T00:00:00Z